Ruben Verloy

Mr. Ruben Verloy

University of Antwerp
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2020 in Cancers
Verified
Journal Article
Open access
PDF file
Ruben VerloyRuben Verloy
Ruben Verloy
Angela Privat MaldonadoAngela Privat Maldonado
Angela Privat Maldonado
ESEvelien Smits
Evelien Smits
Annemie  BogaertsAnnemie Bogaerts
Annemie Bogaerts
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with low five-year survival rates of 8% by conventional treatment methods, e.g., chemotherapy, radiotherapy, and surgery. PDAC shows high resistance towards chemo- and radiotherapy and only 15–20% of all patients can have surgery. This disease is predicted to become the third global leading cause of cancer death due to its significant rise in incidence. Therefore, the development of an alternative or combinational method is necessary to improve current approaches. Cold atmospheric plasma (CAP) treatments could offer multiple advantages to this emerging situation. The plasma-derived reactive species can induce oxidative damage and a cascade of intracellular signaling pathways, which could lead to cell death. Previous reports have shown that CAP treatment also influences cells in the tumor microenvironment, such as the pancreatic stellate cells (PSCs). These PSCs, when activated, play a crucial role in the propagation, growth and survival of PDAC tumors. However, the effect of CAP on PSCs is not yet fully understood. This review focuses on the application of CAP for PDAC treatment and the importance of PSCs in the response to treatment.

Verified
Journal Article
Open access
PDF file
Angela Privat MaldonadoAngela Privat Maldonado
Angela Privat Maldonado
Ruben VerloyRuben Verloy
Ruben Verloy
EDEdgar Cardenas Delahoz
Edgar Cardenas Delahoz
Abraham LinAbraham Lin
Abraham Lin
Steve VanlanduitSteve Vanlanduit
Steve Vanlanduit
Annemie  BogaertsAnnemie Bogaerts
Annemie Bogaerts
Pancreatic ductal adenocarcinoma (PDAC) is a challenging neoplastic disease, mainly due to the development of resistance to radio- and chemotherapy. Cold atmospheric plasma (CAP) is an alternative technology that can eliminate cancer cells through oxidative damage, as shown in vitro, in ovo, and in vivo. However, how CAP affects the pancreatic stellate cells (PSCs), key players in the invasion and metastasis of PDAC, is poorly understood. This study aims to determine the effect of an anti-PDAC CAP treatment on PSCs tissue developed in ovo using mono- and co-cultures of RLT-PSC (PSCs) and Mia PaCa-2 cells (PDAC). We measured tissue reduction upon CAP treatment and mRNA expression of PSC activation markers and extracellular matrix (ECM) remodelling factors via qRT-PCR. Protein expression of selected markers was confirmed via immunohistochemistry. CAP inhibited growth in Mia PaCa-2 and co-cultured tissue, but its effectiveness was reduced in the latter, which correlates with reduced ki67 levels. CAP did not alter the mRNA expression of PSC activation and ECM remodelling markers. No changes in MMP2 and MMP9 expression were observed in RLT-PSCs, but small changes were observed in Mia PaCa-2 cells. Our findings support the ability of CAP to eliminate PDAC cells, without altering the PSCs.

18 March 2025 in Cells
Verified
Journal Article
Open access
PDF file
Ruben VerloyRuben Verloy
Ruben Verloy
Angela Privat MaldonadoAngela Privat Maldonado
Angela Privat Maldonado
JAJonas Van Audenaerde
Jonas Van Audenaerde
Sophie Adriana Josepha Maria RoversSophie Adriana Josepha Maria Rovers
Sophie Adriana Josepha Maria Rovers
HZHannah Zaryouh
Hannah Zaryouh
Annemie  BogaertsAnnemie Bogaerts
Annemie Bogaerts
Pancreatic ductal adenocarcinoma (PDAC) presents significant treatment challenges due to its desmoplastic reaction, which impedes therapeutic effectiveness, highlighting the need for advanced vitro models to better mimic the complex tumor environment. The current three-dimensional co-culture models of fibroblasts and endothelial cells are lacking, which presents a challenge for performing more comprehensive in vitro research. Our study developed triple co-culture spheroid models using MiaPaCa-2 and BxPC-3 cancer cell lines, with RLT-PSC and hPSC21 pancreatic stellate cell lines and the endothelial cell line HMEC-1. These models were assessed through growth assays, multicolor flow cytometry to optimize cell ratios, cell viability assays to evaluate drug responses, and a tube formation assay with a spheroid-conditioned medium to examine angiogenesis. Our triple co-culture spheroids effectively replicate the PDAC microenvironment, showing significant variations in drug responses influenced by cellular composition, density, and spatial arrangement. The tube formation assay showcased the potential of our models to quantitatively assess a treatment-induced angiogenic response. These cost-effective triple-co-culture in vitro spheroid models provide vital insights into the PDAC microenvironment, significantly improving the quality of the in vitro evaluation of treatment responses.

20 December 2023 in Journal of Physics D: Applied Physics
Verified
Journal Article
Closed access
PHPepijn Heirman
Pepijn Heirman
Ruben VerloyRuben Verloy
Ruben Verloy
JBJana Baroen
Jana Baroen
Angela Privat MaldonadoAngela Privat Maldonado
Angela Privat Maldonado
ESEvelien Smits
Evelien Smits
Annemie  BogaertsAnnemie Bogaerts
Annemie Bogaerts
The treatment of a well plate by an atmospheric pressure plasma jet is common for in vitro plasma medicine research. Here, reactive species are largely produced through the mixing of the jet effluent with the surrounding atmosphere. This mixing can be influenced not only by the ambient conditions, but also by the geometry of the treated well. To limit this influence and control the atmosphere, a shielding gas is sometimes applied. However, the interplay between the gas shield and the well geometry has not been investigated. In this work, we developed a 2D-axisymmetric computational fluid dynamics model of the kINPen plasma jet, to study the mixing of the jet effluent with the surrounding atmosphere, with and without gas shield. Our computational and experimental results show that the choice of well type can have a significant influence on the effluent conditions, as well as on the effectiveness of the gas shield. Furthermore, the geometry of the shielding gas device can substantially influence the mixing as well. Our results provide a deeper understanding of how the choice of setup geometry can influence the plasma treatment, even when all other operating parameters are unchanged.

27 October 2025
Verified
Thesis
Closed access
Ruben VerloyRuben Verloy
Ruben Verloy
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal malignancies, with a five-year survival rate below 10%. Its poor prognosis stems from late diagnosis, rapid metastasis, and resistance to conventional therapies. A central contributor is the tumor microenvironment (TME), characterized by dense stroma and pancreatic stellate cells (PSCs), which promote therapy resistance by remodeling the extracellular matrix, inducing hypoxia, and limiting drug penetration. These barriers highlight the need for novel therapeutic strategies. This thesis investigated the potential of cold atmospheric plasma (CAP), a non-thermal partially-ionized gas rich in reactive oxygen and nitrogen species (RONS), as a treatment modality for PDAC. Advanced 3D triple co-culture spheroid models (PDAC cells, PSCs and endothelial cells) and the in ovo chorioallantoic membrane (CAM) assay with intravascular chemotherapy injection were developed and employed to evaluate CAP’s effects on angiogenesis and in combination with standard chemotherapeutics (gemcitabine, paclitaxel). Contrary to expectations to improve drug delivery and efficacy, low-dose CAP did not induce angiogenesis. Instead, it maintained vascular quiescence, reduced VEGF-A secretion, and slightly inhibited endothelial tube formation. CAM assays confirmed unchanged vascularization, underscoring CAP’s context-dependent vascular effects. CAP monotherapy reduced cancer cell viability, with selectivity varying by model. In BxPC-3:hPSC21:HMEC-1 spheroids, CAP damaged both cancer and stellate cells, and enhanced low-dose chemotherapy efficacy, suggesting dose-sparing potential. In MiaPaCa-2:RLT-PSC:HMEC-1 spheroids, CAP preserved stellate cells and slightly enhanced low-dose chemotherapy efficacy, however, in some conditions, combined high-dose chemotherapy and CAP reduced treatment efficacy. CAM experiments confirmed chemotherapy cytotoxicity but showed no consistent benefit from CAP addition. CAP represents a potent but context-dependent therapeutic tool in PDAC. Its effects vary with dose, CAP parameters, tumor type, and TME components, highlighting the potential to reduce required chemotherapy doses at low-doses and the risk of inefficient tumor killing at higher doses. The co-culture models developed herein provide valuable platforms for testing multimodal therapies in a realistic TME context. Future research should refine and standardize CAP treatment parameters and explore its integration with existing therapies, potentially enabling CAP to complement multimodal PDAC treatment.

2 January 2024 in Research Square
Verified
Preprint
Open access
PDF file
Ruben VerloyRuben Verloy
Ruben Verloy
APAngela Privat-Maldonado
Angela Privat-Maldonado
JAJonas Van Audenaerde
Jonas Van Audenaerde
SRSophie Rovers
Sophie Rovers
HZHannah Zaryouh
Hannah Zaryouh
ABAnnemie Bogaerts
Annemie Bogaerts
Background Pancreatic ductal adenocarcinoma (PDAC) poses a significant health threat with poor response to current treatment options. The desmoplastic reaction, characteristic of PDAC, hinders therapeutic efficacy and emphasizes the need for novel in vitro models to study the complex tumor microenvironment and increase translatability. Three-dimensional in vitro co-culture models with clinically relevant numbers of cancer-associated fibroblasts and endothelial cells are still lacking and lead to failure of clinical trials and low improvement of patient survival.Methods MiaPaCa-2 and BxPC-3 cancer cell lines, RLT-PSC and hPSC21 pancreatic stellate cell lines and the endothelial cell line HMEC-1 were seeded in ultra-low-attachment round-bottomed plates to form triple co-culture spheroids. A growth assay including all cell lines was performed to evaluate if DMEM or MCDB131 is most ideal for spheroid formation and culturing. Multi-color flow cytometry was used to quantify cell populations after three days of spheroid formation to optimize the seeding ratios. Drug response profiles of mono-culture and triple co-culture spheroids were made using a cell viability assay. Finally, a tube formation assay with spheroid-conditioned medium was performed to showcase the potential of our model for angiogenic studies.Results We developed a panel of high-throughput triple co-culture spheroid models of pancreatic cancer cells, pancreatic stellate cells and endothelial cells. We were able to capture different facets of PDAC heterogeneity in scope of the tumor microenvironment using two different cancer and stellate cell lines, and one endothelial cell line. Importantly, drug responses varied between mono-culture and triple co-culture spheroids, underlining the impact of the tumor microenvironment, spatial arrangement, and spheroid density on therapeutic outcomes. Gemcitabine and paclitaxel treatments revealed different drug response profiles depending on the combination of BxPC-3 or MiaPaCa-2 with RLT-PSC or hPSC21 in a triple co-culture environment. A tube formation assay showcased the potential of our models to assess angiogenesis, providing a quantitative understanding of a treatment-induced response.Conclusions Our study brings sophisticated high-throughput in vitro models that are easy to reproduce and provide valuable insights into PDAC research to improve translatability and preclinical screening efficacy. In addition, our triple co-culture spheroids are cheap and include the heterogeneity of the PDAC tumor microenvironment.